BRIEF-Synlogic Progresses Clinical And Preclinical Pipeline And Outlines 2018 Catalysts [Reuters]
Synlogic, Inc. (SYBX)
Last synlogic, inc. earnings: 3/12 04:19 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.synlogictx.com/news-and-events/news-releases
Company Research
Source: Reuters
BRIEF-Synlogic Progresses Clinical And Preclinical Pipeline And Outlines 2018 Catalysts | Reuters Reuters Staff 1 Min Read Jan 5 (Reuters) - Synlogic Inc: * SYNLOGIC PROGRESSES CLINICAL AND PRECLINICAL PIPELINE AND OUTLINES 2018 CATALYSTS * SYNLOGIC - EXPECTS TO PRESENT FULL CLINICAL DATA FROM FIRST IN-HUMAN STUDY OF SYNTHETIC BIOTIC MEDICINE EXPECTED IN Q1 2018 * SYNLOGIC INC - IND FOR SYNB1020 FOR TREATMENT OF HYPERAMMONEMIA IN PATIENTS WITH LIVER DISEASE HAS BEEN CLEARED BY FDA * SYNLOGIC INC - ADDITIONAL TRIALS IN PATIENTS WITH UCD AND PKU EXPECTED TO BEGIN IN 2018 Source text for Eikon: Further company coverage: All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays. Š 2018 Reuters. All Rights Reserved. BRIEF-Synlogic Progresses Clinical And Preclinical Pipeline And Outlines 2018 Catalysts Jan 5 (Reuters) - Synlogic Inc: * SYNLOGIC PROGRESSES CLINICAL AND PRECLINICAL PIPELINE AND OUTLINES 2018 CATALYSTS * SYNLOGIC - EXPECTS TO P
Show less
Read more
Impact Snapshot
Event Time:
SYBX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SYBX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SYBX alerts
High impacting Synlogic, Inc. news events
Weekly update
A roundup of the hottest topics
SYBX
News
- Synlogic, Inc. (NASDAQ: SYBX) was upgraded by analysts at HC Wainwright from a "sell" rating to a "neutral" rating.MarketBeat
- Synlogic Reports Fourth Quarter and Full Year 2023 Financial Results [Yahoo! Finance]Yahoo! Finance
- Synlogic Reports Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewswire
- Synlogic Adopts Limited Duration Stockholders Rights Plan [Yahoo! Finance]Yahoo! Finance
- Synlogic Adopts Limited Duration Stockholders Rights PlanGlobeNewswire
SYBX
Earnings
- 11/9/23 - Miss
SYBX
Sec Filings
- 4/29/24 - Form 10-K/A
- 4/22/24 - Form 144
- 4/18/24 - Form SC
- SYBX's page on the SEC website